Investment Rating - The report maintains a "Buy" rating for the company, expecting the stock price to outperform the industry index by more than 15% in the next six months [5][23]. Core Views - The company's organic fluorine business continues to grow, driven by innovation, which supports long-term growth prospects [1]. - The overall sales gross margin for the first half of 2025 is 25.05%, a decrease of 2.83 percentage points compared to the same period in 2024 [2]. - The company has seen significant growth in its operating cash flow, with a net cash flow from operating activities of 569 million, up 321.57% year-on-year [3]. - The company is focusing on technological research and strategic layout to enhance its core competitiveness across four major business modules [10]. Financial Performance Summary - For the first half of 2025, the company reported revenue of 4.248 billion, an increase of 18.58% year-on-year, and a net profit of 484 million, up 16.36% year-on-year [1]. - The company expects revenues of 10.236 billion, 12.634 billion, and 14.115 billion for 2025, 2026, and 2027 respectively, with corresponding net profits of 1.178 billion, 1.537 billion, and 2.030 billion [12]. - The company's three main business segments—battery chemicals, organic fluorine chemicals, and electronic information chemicals—are all experiencing growth, with battery chemicals revenue reaching 2.815 billion, up 22.77% year-on-year [3][9]. Business Segment Performance - The organic fluorine chemicals segment achieved revenue of 722 million, a year-on-year increase of 1.37%, with a gross margin of 62.80% [4]. - The electronic information chemicals segment reported revenue of 679 million, a growth of 25.18% year-on-year, with a gross margin of 47.82% [9]. - The company is enhancing its global layout to meet customer demands, with ongoing projects in Malaysia and the United States to expand its battery chemicals capacity [11].